Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.

Register Now: Turn This Market Crash to Your Advantage (Today 5pm)

REFRESH
Live BSE Quotes Jan 24, 2022 03:36:00 PM
Price (Rs)4,049.95 Open (Rs) 4,180.00 High (Rs) 4,191.95 Low (Rs) 3,790.00
% Change-3.08 Volume 43,226 Value (Rs) 175,063,139 52-Week H/L 5,425.00 / 3,154.50
Live NSE Quotes Jan 24, 2022 3:29:59 PM
Price (Rs)4,056.00 Open (Rs) 4,189.00 High (Rs) 4,190.00 Low (Rs) 3,788.95
% Change-2.95 Volume 1,397,237 Value (Rs) 5,592,860,264 52-Week H/L 5,425.10 / 3,153.30
Change
1 Day
-3.08%
1 Month
-8.94%
3 Months
-18.95%
1 Year
13.42%
5 Years (CAGR)*
42.76%
10 Years (CAGR)*
26.16%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 80.47 P/E Ratio (x) 50.33 Market Cap (Rs m) 1,075,134.56 P/BV (x) 11.57 Dividend Yield (%) 0.49
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was down 3.1% to Rs 4,050.0 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was down 3.0% to Rs 4,056.0. The total volume of shares traded was 1.4 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 2.5%. And the benchmark S&P BSE SENSEX was at 57,491.5 (down 2.6%).

Over the last 30 days, the DIVIS LABORATORIES share price is down 8.1%. And over the last one year, DIVIS LABORATORIES share price is up 12.3%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,075,134.56 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of December 2021, company promoters held 51.95% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Extends Fall, Slumps 1,500 Points; Bajaj Finance, Tech Mahindra and Tata Steel Plunge 5%(01:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red.

Related Views On News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS